Clin2
NCT05285332Possibly a fitNot yet recruiting

Treatment strategy study for newly diagnosed metastatic breast cancer

Breast NeoplasmsTreatmentMetastatic Breast CancerSurvival

Treatments studied

Part of Cancer, Skin clinical trials.

This trial tests a planned treatment approach for people with newly diagnosed (de-novo) metastatic breast cancer that has spread to other parts of the body. It may help doctors find a better way to control the cancer while keeping organs like the liver, kidneys, and bone marrow working well.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
362 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have invasive breast cancer confirmed by pathology (biopsy/pathology report).
  • Your breast cancer is stage IV at diagnosis, meaning it has spread to metastases confirmed by imaging or pathology.
  • Your body function is good enough for study: ECOG score 0–2 (able to do most daily activities).
  • Your bone marrow, liver, and kidneys must be functioning well based on lab tests.
  • You did not already have surgery to remove the main breast tumor in this newly diagnosed stage IV situation.
  • You must not have another primary cancer, and the cancer spread should not involve more than two internal (visceral) organs.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06409390Recruiting· Phase 2
Sequential therapy based on tumor evolution for breast cancer

This trial tests a sequence of different treatments for breast cancer that has spread, based on how the cancer evolves. The goal is to find a personalized treatment plan that may work better over time.

Tampa, Florida
NCT03424005Recruiting· Phase 1/Phase 2
Testing new drug combinations for advanced breast cancer

This study tests how well and how safely different combinations of cancer drugs work for people with metastatic or inoperable locally advanced breast cancer. It may help by finding a better treatment option and collecting information to guide future care.

Duarte, California
NCT02819882Recruiting
Registry study for advanced or metastatic breast cancer

This study collects health and treatment information from people with breast cancer that cannot be fully removed by surgery or that has spread to other parts of the body. It may help researchers better understand which treatments are used and how people do over time.

Elche, Alicante
NCT01042379Recruiting· Phase 2
Adaptive drug trial for newly diagnosed breast cancer

This study tests personalized, changing treatment plans (given before surgery) to find better options for your specific breast tumor. You may be asked for extra breast-tissue testing to help match you with the most suitable study drug(s).

Birmingham, Alabama
NCT06135714Recruiting· Phase 3
Targeting limited breast cancer spread with focused therapy

This trial tests whether treating just the few spots where breast cancer has spread (called oligometastases) with radiation or surgery can help control the disease. It is for people whose cancer has spread to 3 or fewer places, each small in size, and who are healthy enough for local treatments.

Tokyo, Tokyo
NCT05334459Recruiting
Radiation and medicines after surgery for new metastatic breast cancer

This trial looks at giving radiation and anti-cancer medicines after surgery to treat newly diagnosed (de novo) metastatic breast cancer. It may help patients by improving local control of the breast area while also treating cancer throughout the body.

Ankara

Hear when a new Breast Neoplasms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.